Miller GJ - Search Results

1

Genetic and environmental determinants of plasma nitrogen oxides and risk of ischemic heart disease.

Jeerooburkhan N, Jones LC, Bujac S, Cooper JA, Miller GJ, Vallance P, Humphries SE, Hingorani AD. Jeerooburkhan N, et al. Among authors: miller gj. Hypertension. 2001 Nov;38(5):1054-61. doi: 10.1161/hy1101.092967. Hypertension. 2001. PMID: 11711497

2

Substitution of asparagine for aspartic acid at residue 9 (D9N) of lipoprotein lipase markedly augments risk of ischaemic heart disease in male smokers.

Talmud PJ, Bujac SR, Hall S, Miller GJ, Humphries SE. Talmud PJ, et al. Among authors: miller gj. Atherosclerosis. 2000 Mar;149(1):75-81. doi: 10.1016/s0021-9150(99)00309-3. Atherosclerosis. 2000. PMID: 10704617

3

Epidemiological and genetic associations of activated factor XII concentration with factor VII activity, fibrinopeptide A concentration, and risk of coronary heart disease in men.

Zito F, Drummond F, Bujac SR, Esnouf MP, Morrissey JH, Humphries SE, Miller GJ. Zito F, et al. Among authors: miller gj. Circulation. 2000 Oct 24;102(17):2058-62. doi: 10.1161/01.cir.102.17.2058. Circulation. 2000. PMID: 11044420

4

A combination of two common thrombomodulin gene variants (-1208-1209TTdelTT and A455V) influence risk of coronary heart disease: a prospective study in men.

Konstantoulas CJ, Cooper J, Warnock G, Miller GJ, Humphries SE, Ireland H. Konstantoulas CJ, et al. Among authors: miller gj. Atherosclerosis. 2004 Nov;177(1):97-104. doi: 10.1016/j.atherosclerosis.2004.05.032. Atherosclerosis. 2004. PMID: 15488871

5

Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration.

Humphries SE, Lane A, Green FR, Cooper J, Miller GJ. Humphries SE, et al. Among authors: miller gj. Arterioscler Thromb. 1994 Feb;14(2):193-8. doi: 10.1161/01.atv.14.2.193. Arterioscler Thromb. 1994. PMID: 8305408

6

Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease.

Miller GJ, Bauer KA, Barzegar S, Cooper JA, Rosenberg RD. Miller GJ, et al. Thromb Haemost. 1996 May;75(5):767-71. Thromb Haemost. 1996. PMID: 8725721

7

Platelet counts and aggregation measures in the incidence of ischaemic heart disease (IHD).

Meade TW, Cooper JA, Miller GJ. Meade TW, et al. Among authors: miller gj. Thromb Haemost. 1997 Aug;78(2):926-9. Thromb Haemost. 1997. PMID: 9268196

8

Apal polymorphism in insulin-like growth factor II (IGF2) gene and weight in middle-aged males.

O'Dell SD, Miller GJ, Cooper JA, Hindmarsh PC, Pringle PJ, Ford H, Humphries SE, Day IN. O'Dell SD, et al. Among authors: miller gj. Int J Obes Relat Metab Disord. 1997 Sep;21(9):822-5. doi: 10.1038/sj.ijo.0800483. Int J Obes Relat Metab Disord. 1997. PMID: 9376897

9

Activation of the coagulant pathway in cigarette smokers.

Miller GJ, Bauer KA, Cooper JA, Rosenberg RD. Miller GJ, et al. Thromb Haemost. 1998 Mar;79(3):549-53. Thromb Haemost. 1998. PMID: 9531038

10

W64R mutation in beta-3-adrenergic receptor gene and weight in a large population sample.

O'Dell SD, Bolla MK, Miller GJ, Cooper JA, Humphries SE, Day IN. O'Dell SD, et al. Among authors: miller gj. Int J Obes Relat Metab Disord. 1998 Apr;22(4):377-9. doi: 10.1038/sj.ijo.0800598. Int J Obes Relat Metab Disord. 1998. PMID: 9578246

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

572 results

Search Page

Filters